Relmada Therapeutics, Inc.

News

Latest Press Releases, Articles & Media Resources

Press Releases

June 28, 2017
Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program

World recognized leader in depression research and treatment to support and guide development program for dextromethadone. NEW YORK, June 28, 2017 /PRNewswire/ --┬áRelmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Dr. Maurizio Fava has been named chair of the newly formed… Read More ┬╗

More Press Releases

Twitter

View All Tweets